Oligomycin

貨號 Cat. No.
O-500
規格 Size
10 x 1 mg 5mg 5x5mg

Description


Oligomycin




Mitochondrial ATP Synthase Inhibitor












Product#: O-500

























Sizes:
10 x 1 mg
5 mg
5 x 5 mg
 
 
 














M.W.: 789.3










CAS No.: [14110-64-6]












Structure:
 








 












Bioassay:
Oligomycin inhibits  ATP dependent adipogenesis in 3T3-L1 cells.  3T3-L1 preadipocytes were induced to undergo adipocyte differentiation (A-D).  5 days post differentiation, different concentrations of Oligomycin (#O-500) were added (A=0, B=1, C=2, and D=10mg/ml).  After 10 days the cells were stained with Oil Red 0 and visualized by light microscopy.










 







 









References:


























































1.



Chappell, J.B. and Greville, G.D. (1961) Nature 190, 502.



2.


Kagawa, Y. and Racker, E. (1966) J. Biol. Chem. 241, 2461.

3.


Kim, S.B. and Berdanier, C.D. (1999) Am. J. Physiol. Endocrinol. Metab. 277, E702.

4.


Cunningham, C.C. and George, D.T. (1975) J. Biol. Chem. 250, 2036.

5.


Arato-Oshima, T. et al. (1996) J. Biol. Chem. 271, 25604.

6.


Fortes, P.A. and Lee, J.A. (1984) J. Biol. Chem. 259, 11176.

7.


Garrahan, P.J. and Glynn, I.M. (1967) J. Physiol. 192, 217.

8.


Cornelius, F. and Skou, J.C. (1985) Biochim. Biophys. Acta 818, 211.

9.


Martin, W.H. et al. (1994) Proc. Natl. Acad. Sci USA 91, 9881.

10.


Hegyvary, C. (1976) Biochim. Biophys. Acta 422, 365.

11.


Fahn, S. et al. (1966) J. Biol. Chem. 241, 1882.

12.


Fahn, S. et al. (1968) J. Biol. Chem. 243, 1993.

13.



Inturrisi, C.E. and Titus, E. (1968) Mol. Pharmacol. 4, 591.




 



Oligomycin is a natural antibiotic isolated from Streptomyces diastatochromogenes



 which inhibits mitochondrial H+-ATP synthase. It is primarily found to act as an inhibitor of mitochondrial respiration and swelling. This antibiotic is widely used as an inhibitor of oxidative phosphorylation.1-2 6-16

These inhibitory properties have been attributed to its ability to occlude the transition of E1~P (high energy intermediate) to E2-P (low energy intermediate) by oligomycin binding to E1~P.17


 



Oligomycin inhibits the H+- ATP-synthase by binding to the Oligomycin sensitivity-conferring protein (OSCP) at the F(o) subunits 6 and 9  which are found in the stalk of the F1F0-ATPase complex. This binding blocks the proton conductance and inhibits the synthesis of mitochondrial ATP.3-4 Because of its activity, it can also be used to reduce the number of parameters (such as ER Ca2+ release, exocytotoxicity and apopotosis) which are affected by mitochondrial depolarization.5

Oligomycin at high concentrations may also inhibit the plasma membrane Na+-K+-ATPase. Interaction of Oligomycin with the Na+ occlusion site on the extracellular side of Na/K-ATPase, delays Na+ release to the extracellular side without inducing a conformational change. Although Oligomycin stimulated Na+ binding to Na+/K+-ATPase, it inhibited  Na+/Na+ exchange, and did not affect either Na+-dependent AD/-ATP exchange or K+-dependent phosphatase activity.


詢價 / 洽詢此產品

回到產品列表

▲ LINE
諮詢